D.A. Davidson & CO. decreased its holdings in shares of Silicon Laboratories, Inc. (NASDAQ:SLAB – Free Report) by 6.1% during the second quarter, according to its most recent filing with the SEC. The firm owned 1,674 shares of the semiconductor company’s stock after selling 109 shares during the period. D.A. Davidson & CO.’s holdings in Silicon Laboratories were worth $247,000 at the end of the most recent reporting period.
A number of other institutional investors have also added to or reduced their stakes in the business. West Tower Group LLC purchased a new position in Silicon Laboratories during the 2nd quarter valued at about $295,000. Allianz Asset Management GmbH increased its position in Silicon Laboratories by 9.2% during the 2nd quarter. Allianz Asset Management GmbH now owns 167,835 shares of the semiconductor company’s stock valued at $24,732,000 after purchasing an additional 14,077 shares during the period. Davidson Investment Advisors grew its position in shares of Silicon Laboratories by 1.0% in the 2nd quarter. Davidson Investment Advisors now owns 145,982 shares of the semiconductor company’s stock worth $21,512,000 after buying an additional 1,480 shares during the last quarter. Bayforest Capital Ltd grew its position in shares of Silicon Laboratories by 276.5% in the 2nd quarter. Bayforest Capital Ltd now owns 7,542 shares of the semiconductor company’s stock worth $1,111,000 after buying an additional 5,539 shares during the last quarter. Finally, CWM LLC raised its stake in shares of Silicon Laboratories by 137.0% during the 2nd quarter. CWM LLC now owns 2,237 shares of the semiconductor company’s stock worth $330,000 after acquiring an additional 1,293 shares in the last quarter.
Analysts Set New Price Targets
Several brokerages have weighed in on SLAB. Barclays raised their target price on shares of Silicon Laboratories from $100.00 to $130.00 and gave the company an “equal weight” rating in a research note on Tuesday, August 5th. Susquehanna raised their target price on shares of Silicon Laboratories from $110.00 to $150.00 and gave the company a “neutral” rating in a research note on Tuesday, July 22nd. Morgan Stanley lowered their target price on shares of Silicon Laboratories from $157.00 to $144.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 6th. Weiss Ratings restated a “sell (d-)” rating on shares of Silicon Laboratories in a research note on Wednesday, October 8th. Finally, KeyCorp raised their target price on shares of Silicon Laboratories from $160.00 to $180.00 and gave the company an “overweight” rating in a research note on Tuesday, July 8th. Five equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $151.13.
Insiders Place Their Bets
In other Silicon Laboratories news, SVP Brandon Tolany sold 1,800 shares of the business’s stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $133.57, for a total transaction of $240,426.00. Following the sale, the senior vice president owned 62,328 shares of the company’s stock, valued at approximately $8,325,150.96. The trade was a 2.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Over the last quarter, insiders have sold 12,070 shares of company stock worth $1,703,472. 1.60% of the stock is currently owned by insiders.
Silicon Laboratories Trading Down 0.4%
NASDAQ:SLAB opened at $131.74 on Friday. The company has a market cap of $4.32 billion, a PE ratio of -40.91 and a beta of 1.51. Silicon Laboratories, Inc. has a twelve month low of $82.82 and a twelve month high of $160.00. The company’s 50 day moving average is $134.44 and its two-hundred day moving average is $130.20.
Silicon Laboratories (NASDAQ:SLAB – Get Free Report) last released its earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.02. The company had revenue of $192.85 million for the quarter, compared to the consensus estimate of $192.57 million. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. Silicon Laboratories’s revenue was up 32.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.56) EPS. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. As a group, analysts expect that Silicon Laboratories, Inc. will post -0.97 EPS for the current fiscal year.
About Silicon Laboratories
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Read More
- Five stocks we like better than Silicon Laboratories
- The Risks of Owning Bonds
- Why Microsoft’s Post-Earnings Dip Is a Buy-the-Pause Moment
- Where Do I Find 52-Week Highs and Lows?
- NVIDIA’s Billion-Dollar Bet Puts Nokia Back in the Growth Game
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
